Goldman Sachs’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-17,800
Closed -$643K – 6489
2025
Q1
$643K Buy
+17,800
New +$548K ﹤0.01% 5028
2020
Q2
– Sell
-15,000
Closed -$772K – 5522
2020
Q1
$772K Buy
+15,000
New +$782K ﹤0.01% 3930

Other funds holding ZLAB

Goldman Sachs's ZLAB Position: Q3 2026 in Review

Goldman Sachs reduced its Zai Lab (ZLAB) stake by 17% in Q3 2026, selling an estimated $9.31M and leaving 1,912,532 shares worth $50.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1700.

Goldman Sachs first reported a position in ZLAB in Q3 2017 and has held it in 34 quarters since. The position peaked at $87.8M in Q3 2020. 103 funds tracked by Wall St. Rank hold ZLAB as of Q3 2026.

  • Goldman Sachs held 1,912,532 shares of Zai Lab worth $50.4M as of Q3 2026.
  • Goldman Sachs sold 402,948 Zai Lab shares in Q3 2026, an estimated $9.31M.
  • Zai Lab made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #1700 holding.
  • Goldman Sachs first reported a position in Zai Lab in Q3 2017 and has held it in 34 quarters since.
  • Goldman Sachs's Zai Lab position peaked at $87.8M in Q3 2020.
  • 103 funds tracked by Wall St. Rank held Zai Lab as of Q3 2026.

Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.